Integra LifeSciences Enrolls 100th Patient in AERA Pediatric Registry
MT Newswires Live
Sep 29
Integra LifeSciences (IART) has enrolled its 100th patient in a prospective, multicenter observational registry evaluating the real-world clinical performance of the Acclarent AERA Eustachian Tube Balloon Dilation System in pediatric patients aged eight years or older, the company said Tuesday.
The AERA Pediatric Registry is designed to generate real-world evidence regarding the use of the system in children with obstructive Eustachian tube dysfunction, according to a statement.
Integra said it is targeting enrollment of 300 patients.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.